Implies the FDA can use their reasoning ability to
Post# of 148183
Refreshing, optimistic.
However, the FDA credibility has been tarnished by their approvals of remdeathsivir and plasma, so they IMO, have stuck their foot in the door of the DSMB and are being "tedious" to be sure that their upcoming decision for EUA for Leronlimab will be a solid move (as we know it will).